190 related articles for article (PubMed ID: 35455981)
1. MicroRNA-like snoRNA-Derived RNAs (sdRNAs) Promote Castration-Resistant Prostate Cancer.
Coley AB; Stahly AN; Kasukurthi MV; Barchie AA; Hutcheson SB; Houserova D; Huang Y; Watters BC; King VM; Dean MA; Roberts JT; DeMeis JD; Amin KV; McInnis CH; Godang NL; Wright RM; Haider DF; Piracha NB; Brown CL; Ijaz ZM; Li S; Xi Y; McDonald OG; Huang J; Borchert GM
Cells; 2022 Apr; 11(8):. PubMed ID: 35455981
[TBL] [Abstract][Full Text] [Related]
2. C/D-box snoRNA-derived RNA production is associated with malignant transformation and metastatic progression in prostate cancer.
Martens-Uzunova ES; Hoogstrate Y; Kalsbeek A; Pigmans B; Vredenbregt-van den Berg M; Dits N; Nielsen SJ; Baker A; Visakorpi T; Bangma C; Jenster G
Oncotarget; 2015 Jul; 6(19):17430-44. PubMed ID: 26041889
[TBL] [Abstract][Full Text] [Related]
3. Small Nucleolar Derived RNAs as Regulators of Human Cancer.
Coley AB; DeMeis JD; Chaudhary NY; Borchert GM
Biomedicines; 2022 Jul; 10(8):. PubMed ID: 36009366
[TBL] [Abstract][Full Text] [Related]
4. Human snoRNA-93 is processed into a microRNA-like RNA that promotes breast cancer cell invasion.
Patterson DG; Roberts JT; King VM; Houserova D; Barnhill EC; Crucello A; Polska CJ; Brantley LW; Kaufman GC; Nguyen M; Santana MW; Schiller IA; Spicciani JS; Zapata AK; Miller MM; Sherman TD; Ma R; Zhao H; Arora R; Coley AB; Zeidan MM; Tan M; Xi Y; Borchert GM
NPJ Breast Cancer; 2017; 3():25. PubMed ID: 28702505
[TBL] [Abstract][Full Text] [Related]
5. Sno-derived RNAs are prevalent molecular markers of cancer immunity.
Chow RD; Chen S
Oncogene; 2018 Dec; 37(50):6442-6462. PubMed ID: 30072739
[TBL] [Abstract][Full Text] [Related]
6. Human box C/D snoRNA processing conservation across multiple cell types.
Scott MS; Ono M; Yamada K; Endo A; Barton GJ; Lamond AI
Nucleic Acids Res; 2012 Apr; 40(8):3676-88. PubMed ID: 22199253
[TBL] [Abstract][Full Text] [Related]
7. SnoRNAs and the emerging class of sdRNAs: Multifaceted players in oncogenesis.
Abel Y; Rederstorff M
Biochimie; 2019 Sep; 164():17-21. PubMed ID: 31078583
[TBL] [Abstract][Full Text] [Related]
8. RNA-Seq of the nucleolus reveals abundant SNORD44-derived small RNAs.
Bai B; Yegnasubramanian S; Wheelan SJ; Laiho M
PLoS One; 2014; 9(9):e107519. PubMed ID: 25203660
[TBL] [Abstract][Full Text] [Related]
9. Androgen receptor-regulated miRNA-193a-3p targets AJUBA to promote prostate cancer cell migration.
Jia L; Gui B; Zheng D; Decker KF; Tinay I; Tan M; Wang X; Kibel AS
Prostate; 2017 Jun; 77(9):1000-1011. PubMed ID: 28422308
[TBL] [Abstract][Full Text] [Related]
10. Functional roles of miR-625-5p and miR-874-3p in the progression of castration resistant prostate cancer.
Aktan Ç; Çal Ç; Kaymaz B; Selvi Günel N; Kıpçak S; Özel B; Gündüz C; Şahin Küçükaslan A; Aygüneş Jafari D; Kosova B
Life Sci; 2022 Jul; 301():120603. PubMed ID: 35508255
[TBL] [Abstract][Full Text] [Related]
11. MYBL2 disrupts the Hippo-YAP pathway and confers castration resistance and metastatic potential in prostate cancer.
Li Q; Wang M; Hu Y; Zhao E; Li J; Ren L; Wang M; Xu Y; Liang Q; Zhang D; Lai Y; Liu S; Peng X; Zhu C; Ye L
Theranostics; 2021; 11(12):5794-5812. PubMed ID: 33897882
[No Abstract] [Full Text] [Related]
12. Role of protein S in castration-resistant prostate cancer-like cells.
Ning P; Zhong JG; Jiang F; Zhang Y; Zhao J; Tian F; Li W
Endocr Relat Cancer; 2016 Aug; 23(8):595-607. PubMed ID: 27342144
[TBL] [Abstract][Full Text] [Related]
13. Androgen receptor-mediated downregulation of microRNA-221 and -222 in castration-resistant prostate cancer.
Gui B; Hsieh CL; Kantoff PW; Kibel AS; Jia L
PLoS One; 2017; 12(9):e0184166. PubMed ID: 28886115
[TBL] [Abstract][Full Text] [Related]
14. NPRL2 enhances autophagy and the resistance to Everolimus in castration-resistant prostate cancer.
Chen Z; Jiang Q; Zhu P; Chen Y; Xie X; Du Z; Jiang L; Tang W
Prostate; 2019 Jan; 79(1):44-53. PubMed ID: 30178500
[TBL] [Abstract][Full Text] [Related]
15. Global Switch from DICER-dependent MicroRNA to DICER-independent SnoRNA-derived RNA Biogenesis in Malignancy.
Godang NL; DeMeis JD; Houserova D; Chaudhary NY; Salter CJ; Xi Y; McDonald OG; Borchert GM
MicroPubl Biol; 2023; 2023():. PubMed ID: 36818311
[TBL] [Abstract][Full Text] [Related]
16. Beyond microRNA--novel RNAs derived from small non-coding RNA and their implication in cancer.
Martens-Uzunova ES; Olvedy M; Jenster G
Cancer Lett; 2013 Nov; 340(2):201-11. PubMed ID: 23376637
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA Regulation of Androgen Receptor in Castration-Resistant Prostate Cancer: Premises, Promises, and Potentials.
Ebrahimi S; Hashemy SI; Sahebkar A; Aghaee Bakhtiari SH
Curr Mol Pharmacol; 2021 Oct; 14(4):559-569. PubMed ID: 33357209
[TBL] [Abstract][Full Text] [Related]
18. Androgen receptors in hormone-dependent and castration-resistant prostate cancer.
Shafi AA; Yen AE; Weigel NL
Pharmacol Ther; 2013 Dec; 140(3):223-38. PubMed ID: 23859952
[TBL] [Abstract][Full Text] [Related]
19. LPCAT1 enhances castration resistant prostate cancer progression via increased mRNA synthesis and PAF production.
Han C; Yu G; Mao Y; Song S; Li L; Zhou L; Wang Z; Liu Y; Li M; Xu B
PLoS One; 2020; 15(11):e0240801. PubMed ID: 33137125
[TBL] [Abstract][Full Text] [Related]
20. Transcript Levels of Androgen Receptor Variant 7 and Ubiquitin-Conjugating Enzyme 2C in Hormone Sensitive Prostate Cancer and Castration-Resistant Prostate Cancer.
Lee CH; Ku JY; Ha JM; Bae SS; Lee JZ; Kim CS; Ha HK
Prostate; 2017 Jan; 77(1):60-71. PubMed ID: 27550197
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
